{"id":"https://genegraph.clinicalgenome.org/r/58ee9486-f2f9-45bd-ad5c-f3a3ed414ad4v1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between HPDL and Leigh syndrome spectrum (LSS) was evaluated using the ClinGen Clinical Validity Framework as of June 30, 2021. The HPDL gene encodes 4-hydroxyphenylpyruvate dioxygenase-like protein, a putative iron-containing oxygenase. The mechanism underlying how pathogenic variants in this gene affect mitochondria and cause disease is unclear.\n\nThe HPDL gene was first reported in relation to autosomal recessive LSS in 2020 (PMID: 32707086). Evidence supporting the relationship between HPDL and LSS includes case-level data and experimental data. This curation included nine unique variants identified in five cases from two publications (PMID: 32707086, 33970200).  Of note, variants in HPDL have also been associated with infantile-onset encephalopathy and spastic paraplegia. No segregation data were available. Loss of function is implicated as the mechanism of disease. This gene-disease association is also supported by expression and animal models (PMIDs: 18853439, 33188300).\n\nIn summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on June 30, 2021 (SOP Version 7).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/58ee9486-f2f9-45bd-ad5c-f3a3ed414ad4","GCISnapshot":"https://genegraph.clinicalgenome.org/r/d1a484ba-cba2-4a63-8c81-7a8a41c93f9c","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/d1a484ba-cba2-4a63-8c81-7a8a41c93f9c_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2021-06-30T21:58:01.685Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/d1a484ba-cba2-4a63-8c81-7a8a41c93f9c_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2021-06-30T21:57:54.231Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1a484ba-cba2-4a63-8c81-7a8a41c93f9c_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1a484ba-cba2-4a63-8c81-7a8a41c93f9c_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6430f256-1d72-49d2-978a-3c5c93e3fcff","type":"EvidenceLine","dc:description":"0.5pts: failure to thrive and early death\n0.5pts: reduction in growth rate","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/38845736-d09c-4dc6-9d3d-e1ba5b7719a7","type":"Finding","dc:description":"A KO mouse model was created with a a homozygous frameshift deletion of Hpdl generated using CRISPR/Cas9.\nMice are born healthy but by day 5 show lethargy and spontaneous movements suggesting of epileptic seizures.\nAlmost all KOs died by P10, and none survived to P15 (Fig. 3a).\nTheir body weights and brain size were similar at birth compared to wildtype littermates but by P9â€“10 the KO mice weighed approximately half that of the wiltype, CC3 staining suggested cellular apoptosis in brain tissues. \nMetabolic analysis showed no abnormal tyrosine catabolism.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33188300","rdfs:label":"HPDL KO mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d1a484ba-cba2-4a63-8c81-7a8a41c93f9c_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/437311f6-15ff-4795-9c75-ac7177f6fd82","type":"EvidenceLine","dc:description":"Default score for expression in the brain.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/18fadab9-b1e9-4644-883a-ae3ca2a413b9","type":"Finding","dc:description":"HPDL is present in various tissues with particularly high levels in the central and peripheral nervous system (GTEx Analysis Release V.8, dbGaP Accession phs000424.v8.p2 on 03/10/2020).\nProtein Atlas: no protein expression data available. High expression in the retina,  expression throighout the brain, higher within the cerebellum. xpression within the GI tract (Stomach, small intestine and colon).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18853439","rdfs:label":"Protein Atlas expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d1a484ba-cba2-4a63-8c81-7a8a41c93f9c_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/143ec3f3-f478-4ead-a038-ffa67d1d162e_proband_score_evidence_line","type":"EvidenceLine","dc:description":"c.503 G>A(p.Cys168Tyr); c.537G>C(p.Trp179Cys)\nFibroblasts  show significantly reduced levels of HPDL protein by western blot.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39dca7f4-363c-4578-a03a-842bd3d90f22","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32707086","rdfs:label":"F6:II.1","ageType":"AgeAtOnset","ageUnit":"Weeks","ageValue":3,"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Developmental delay-motor; mild ID, microcephaly, seizures, spastic paraplegia, visual disturbance (summary Table 1). Acute respiratory failure at 3 weeks\nreduced sensory Nerve Conduction Velocity\nChronic progression\nMRI:'pattern 1' Brain MRI showed dysgenesis of the corpus callosum and unilateral small punctiform lesions of the left basal ganglia with diffusion restriction, Unilateral involvement, further detail given in supplementary text of repeat scans. Figure 2.\nIncreased lactate by MRS, blood lactate: 7.9mmol/l, csf lactate: 8.2 mmol/l\nMuscle biopsy, normal histology but CIV deficiency\nFibroblasts: increased complex V\nFH: affected brother, similar phenotype, muscle biopsy showed CIV deficiency; fibroblasts showed increased complex V activity","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/143ec3f3-f478-4ead-a038-ffa67d1d162e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32707086","allele":[{"id":"https://genegraph.clinicalgenome.org/r/80590922-3760-4f5c-ab9d-17bfa909c418","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032756.3(HPDL):c.537G>C (p.Trp179Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/979211"}},{"id":"https://genegraph.clinicalgenome.org/r/d5a4cf4a-1e10-4f3a-bea5-3b6977826dd4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032756.3(HPDL):c.503G>A (p.Cys168Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/979210"}}]}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/82d5454f-4256-4f3a-97c9-820cc5a3051b_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Fibroblasts from F8II.1 show significantly reduced levels of HPDL protein by western blot.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0bfa25bd-1d22-4992-9ac9-afa53bc933e6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32707086","rdfs:label":"F8:II.1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":5,"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Developmental delay-motor; mild ID, microcephaly, spastic paraplegia, visual disturbance (summary Table 1).\nChronic progression, \nElevated blood lactate 4.3mmol/l; csf 3.3 mmol/l\nMuscle biopsy showed abnormal variation in muscle fiber diameter\nMRI (Figure 2) showed multifocal and confluent signal changes bilaterally (hyperintensities on T2-weighted scans and with some moderate ADC decrease) of basal ganglia (nucleus caudatus and putamen); myelination low normal (optic radiation, PLIC, central white matter, cerebellar white matter showed low T2-weighted signal): classical bilateral appearance of the striatal lesions with variable degrees of signal changes.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/82d5454f-4256-4f3a-97c9-820cc5a3051b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32707086","allele":[{"id":"https://genegraph.clinicalgenome.org/r/418e1372-f3cb-4144-83d7-3a22bd91995f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032756.3(HPDL):c.469T>C (p.Trp157Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA826252"}},{"id":"https://genegraph.clinicalgenome.org/r/675faf88-b377-4d3c-bd44-c97bb0c15cb8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032756.3(HPDL):c.753C>A (p.His251Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340130042"}}]}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/8a0ef028-fe51-4598-af9b-8a6eec3abb89_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Default scoring for nonsense variant","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef21699b-345e-4000-81e7-098c05df5b02","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33970200","rdfs:label":"CS4","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":10,"phenotypeFreeText":"global developmental delay, regression, MRS lactate peak over basal ganglia, elevated CSF lactate","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8a0ef028-fe51-4598-af9b-8a6eec3abb89_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33970200","allele":[{"id":"https://genegraph.clinicalgenome.org/r/e04bbbdf-0d1a-4a98-bf44-98aece13fdd3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032756.4(HPDL):c.27C>A (p.Cys9Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340127434"}},{"id":"https://genegraph.clinicalgenome.org/r/e12e2e1c-398c-496b-bf0f-60d81f3b7bb0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032756.4(HPDL):c.569C>T (p.Pro190Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA826270"}}],"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4c1a05fc-4478-41a6-8de2-c7ad3521bf2b_proband_score_evidence_line","type":"EvidenceLine","dc:description":"HPDL is a single exon gene but the predicted protein truncation results in 35% loss of protein sequence. Scored default.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fa92cf43-fe9b-4b7f-a8a3-a628d7f4501f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32707086","rdfs:label":"F3:II.3","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":6,"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Developmental delay-motor; moderate ID, seizures, spastic paraplegia, visual disturbance (summary Table 1)\nEpisodes of acute respiratory failure at age 11 years, \nChronic progression and regression\nLactate on MRS and elevated blood lactate 5.2mmol.l CSF 2.7mmol/l\nA series of MRI scans are described in the case data and include description of bilateral lesions within the brain stem and thalamus. (typical distribution of the brainstem lesions in LSS) Fig 3 A-P","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4c1a05fc-4478-41a6-8de2-c7ad3521bf2b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32707086","allele":{"id":"https://genegraph.clinicalgenome.org/r/f8d3996c-31f8-4473-b7a1-b371125ef47e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032756.3(HPDL):c.721C>T (p.Gln241Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340129937"}}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/830c3398-c721-452e-9551-63c16e86dd7a_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Case is de novo for p.Leu248Pro. (Paternity assumed)","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0094ccfb-cecc-4e30-80be-ff1360434ac0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32707086","rdfs:label":"F7:II.2","ageType":"AgeAtOnset","ageUnit":"Weeks","ageValue":6,"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Developmental delay-motor; severe ID, microcephaly, seizures, spastic paraplegia (summary Table 1). \nMRI: pattern 1 (Fig. 2) bilat striatal involvement with reversible changes without signs of atrophy (uncommon, but possible.)\nElevated lactate: csf 3.8 mmol/l\nreduced sensory NCV, unilateral\nMuscle biopsy showed abnormal variation in muscle fiber diameter","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/830c3398-c721-452e-9551-63c16e86dd7a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32707086","allele":[{"id":"https://genegraph.clinicalgenome.org/r/5b9793ca-8c24-4b8c-abb8-9c2cb55efcb8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032756.3(HPDL):c.701T>C (p.Leu234Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA826305"}},{"id":"https://genegraph.clinicalgenome.org/r/98d99616-62f9-4d6a-ae46-03dc01611328","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032756.3(HPDL):c.743T>C (p.Leu248Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340130016"}}],"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":8}],"evidenceStrength":"Moderate","sequence":3075,"specifiedBy":"GeneValidityCriteria7","strengthScore":10,"subject":{"id":"https://genegraph.clinicalgenome.org/r/DpOcopLBrBc","type":"GeneValidityProposition","disease":"obo:MONDO_0009723","gene":"hgnc:28242","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_d1a484ba-cba2-4a63-8c81-7a8a41c93f9c-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}